Scarnecchia Elisa, Liparulo Valeria, Capozzi Rosanna, Ceccarelli Silvia, Puma Francesco, Vannucci Jacopo
Department of Thoracic Surgery, University of Perugia medical School, Santa Maria della Misericordia Hospital, Perugia, Italy.
J Thorac Dis. 2018 Jun;10(Suppl 16):S1855-S1863. doi: 10.21037/jtd.2018.05.191.
Tumors of the chest wall have a large spectrum of well-assessed indications for resection. However, whether a reconstruction is required or not is not always clear. Complications after chest wall resection and reconstruction (CWRR) are described in literature and potentially severe. There is no evidence of how non-reconstructive management may influence the post-operative complication rate.
A total of 71 patients underwent thoracic demolition for tumors between April 2000 and October 2016. The patients were divided into two groups based on pathological findings: group 1: primary chest wall tumors; group 2: non-small cell lung cancer (NSCLC) invading the thoracic wall. They were then retrospectively analyzed by means of following criteria: TNM staging, histology, infiltration depth, 5-year survival, overall survival (OS), disease-free survival (DFS), relapse rate, R-0 resection, number of resected ribs, site of surgical resection and post-operative respiratory complications, flail chest, chronic pain, deformity of the chest wall and cosmetic results.
Five-year survival, OS, DFS and risk of relapse showed a significant correlation with the presence of free surgical margins in both groups. In group 2, another parameter which correlated to survival, risk of relapse and DFS was lymph-nodal status. Moreover, the risk of post-operative respiratory complications was directly correlated with non-reconstruction after demolition of the chest wall in certain topographical sites.
free surgical margins are the main oncological prognostic factor in these patients. In patients who underwent resection of two or more ribs in a critical area, reconstruction of the bony thorax can significantly reduce the post-operative respiratory complication rate.
胸壁肿瘤有一系列评估充分的切除指征。然而,是否需要重建并不总是明确的。胸壁切除与重建(CWRR)后的并发症在文献中有描述,且可能很严重。尚无证据表明非重建性处理如何影响术后并发症发生率。
2000年4月至2016年10月期间,共有71例患者因肿瘤接受胸廓切除术。根据病理结果将患者分为两组:第1组:原发性胸壁肿瘤;第2组:侵犯胸壁的非小细胞肺癌(NSCLC)。然后通过以下标准对其进行回顾性分析:TNM分期、组织学、浸润深度、5年生存率、总生存期(OS)、无病生存期(DFS)、复发率、R-0切除、切除肋骨数量、手术切除部位以及术后呼吸并发症、连枷胸、慢性疼痛、胸壁畸形和美容效果。
两组的5年生存率、OS、DFS和复发风险均与手术切缘阴性显著相关。在第2组中,另一个与生存、复发风险和DFS相关的参数是淋巴结状态。此外,在某些地形部位,胸壁切除术后的呼吸并发症风险与未重建直接相关。
手术切缘阴性是这些患者主要的肿瘤学预后因素。在关键区域切除两根或更多肋骨的患者中,胸廓重建可显著降低术后呼吸并发症发生率。